IL13RA2 and neoplasm: For example, a recurrent GBM (rGBM) patient obtained tumor intracranial and spinal regression after intracranial administration of IL-13Rα2-targeted CAR-T cells, but IL-13Rα2-negative tumors resulted in a subsequent relapse (147).